Wildfire Smoke Can Disrupt Medication-Assisted Treatment Access

When Canadian wildfire smoke pushed air quality into hazardous territory across the Midwest and Northeast this month, the public health guidance was simple. Stay inside.

For anyone in medication-assisted treatment for opioid use disorder, that guidance collided with a requirement that cannot be met from a living room, since both methadone and buprenorphine depend on showing up in person.

Smoke from Canadian wildfires covered much of the country from July 14 through July 20, 2026, and more than 120 million Americans were advised to limit outdoor activity, according to a Medical Daily analysis.

Detroit and Minneapolis logged their highest air quality index readings in 27 years, and on July 16 those cities plus Chicago ranked as the three most polluted major cities in the world by IQAir’s count.

Fine particulate levels near Baltimore and Washington approached 200 micrograms per cubic meter, well past the 55 the Environmental Protection Agency calls very unhealthy for all groups.

Why Medication-Assisted Treatment Continuity Matters

Buprenorphine and methadone are not comfort measures. They are FDA-approved medications that prevent opioid withdrawal, suppress cravings, and keep people alive, and their access rules are strict.

Methadone for opioid use disorder can only be dispensed through federally regulated opioid treatment programs, which under most frameworks means daily in-person visits unless a patient has earned take-home doses.

Buprenorphine is more flexible, since any licensed clinician can prescribe it and a retail pharmacy can fill it, but keeping an active prescription still requires regular clinic or pharmacy contact. When travel becomes unsafe, both turn into barriers.

What the Research Actually Shows

A 2022 analysis by researchers at the University of California, Davis examined patients on long-term opioid prescriptions, including buprenorphine for opioid use disorder, after the 2018 Camp Fire in Northern California.

Using state prescription drug monitoring data, the team found that in the hardest-hit ZIP codes, the share of patients with a late fill, meaning a gap of more than two weeks, quadrupled after the disaster.

Iraklis Tseregounis, a UC Davis drug use researcher and the analysis lead author, put the stakes plainly, saying patients need continued access “otherwise they could have fatal consequences.”

Other disasters produced similar patterns. One study estimated that after Superstorm Sandy in 2012, roughly 70 percent of New York area patients relying on opioid recovery medications could not get an adequate supply, and overdose reports in Puerto Rico rose in the two years after Hurricane Maria.

What the Evidence Does Not Show

An air quality emergency is different. When smoke rather than fire is the problem, clinics remain standing and pharmacies stay open, but patients cannot safely travel to them.

The scale of disruption from a smoke-only event has not been formally studied, and the 2022 analysis looked at prescription opioid access broadly rather than isolating buprenorphine and methadone.

What is well established, regardless of why a gap occurs, is the biological risk of stopping these medications abruptly.

Understanding Withdrawal Risk During a Treatment Gap

For someone in medication-assisted treatment who misses doses, withdrawal from short-acting medications typically begins within 12 to 24 hours, bringing muscle aches and cramps, sweating and chills, nausea and vomiting, anxiety and insomnia, and intense cravings.

Opioid withdrawal is rarely directly fatal in an otherwise healthy adult. The danger is downstream. Tolerance drops quickly during a gap, so a previously tolerated dose can become lethal on return to use, which is why an interruption raises overdose risk rather than simply causing discomfort.

Steps to Protect Treatment Continuity

If you or someone you support is in an area under an air quality advisory:

• Contact the program or prescriber now, before conditions worsen, and ask about emergency take-home dose provisions or a telehealth refill visit
• Ask whether the program has a written disaster protocol. Programs that operated under pandemic-era waivers for extended take-home methadone may have kept similar policies
• Ask whether emergency circumstances can accelerate a take-home eligibility review if you have not yet qualified
• Keep naloxone in the household and make sure someone else knows how to use it, since relapse risk climbs during a gap
• Call SAMHSA’s National Helpline at 1-800-662-4357 if you cannot reach your provider

Programs can reduce exposure by contacting high-risk patients ahead of extended advisories. An April 2026 editorial in the American Journal of Public Health argued that current regulations make medication-assisted treatment hard enough to reach normally and nearly impossible during a disaster, and proposed stocking rescue vehicles with buprenorphine, adding backup generators at opioid treatment clinics, and training volunteer disaster responders.

Finding Medical Detox and MAT Programs

If you are looking for medically supervised care, ask programs how they handle emergency access, whether they offer telehealth refills, and what their take-home policy is. Those questions are rarely asked at intake and matter more than people expect.

Never attempt alcohol or benzodiazepine withdrawal without medical supervision. Detox.com’s directory can help you compare medically supervised detox and medication-assisted treatment programs by location and level of care. Call 800-996-6135(Sponsored) to get in touch with a treatment specialist today.